keyword
MENU ▼
Read by QxMD icon Read
search

hyperplasia of prostate

keyword
https://www.readbyqxmd.com/read/30553615/urethra-and-ejaculation-preserving-robot-assisted-simple-prostatectomy-near-infrared-fluorescence-imaging-guided-madigan-technique
#1
Giuseppe Simone, Leonardo Misuraca, Umberto Anceschi, Francesco Minisola, Mariaconsiglia Ferriero, Salvatore Guaglianone, Gabriele Tuderti, Michele Gallucci
BACKGROUND: With the increasing adoption of novel technologies and anatomical techniques, surgical management of benign prostatic hyperplasia (BPH) provides significant benefits in terms of obstruction relief, early urethral catheter removal, and faster return to daily activities. However, the main pitfall of BPH surgery in sexually active men remains ejaculatory dysfunction (EjD), which permanently affects quality of life. OBJECTIVE: To detail a novel technique for marking the intraprostatic urethra through a retrograde injection of indocyanine green to enhance selective dissection of prostatic lobes during urethra-sparing robot-assisted simple prostatectomy (US-RASP) with the use of near-infrared fluorescence imaging (NIFI)...
December 12, 2018: European Urology
https://www.readbyqxmd.com/read/30552937/randomized-controlled-trial-of-aquablation-vs-transurethral-resection-of-the-prostate-in-benign-prostatic-hyperplasia-one-year-outcomes
#2
Peter Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark Sutton, Tev Aho, Eugene Kramolowsky, Andrew Thomas, Barrett Cowan, Claus Roehrborn
OBJECTIVE: To report 1-year safety and efficacy outcomes after either Aquablation or TURP for the treatment of lower urinary tract symptoms related to BPH. METHODS: This double-blinded, multicenter prospective randomized controlled trial assigned 181 patients with BPH-related moderate-to-severe lower urinary tract symptoms to either electrocautery-based prostate resection (TURP) or Aquablation. Efficacy endpoints included reduction in International Prostate Symptom Score and improvement in uroflow parameters...
December 12, 2018: Urology
https://www.readbyqxmd.com/read/30552307/drug-adherence-and-drug-related-problems-in-pharmacotherapy-for-lower-urinary-tract-symptoms-related-to-benign-prostatic-hyperplasia
#3
T Zabkowski, M Saracyn
Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) is one of the most common urinary disorders in elderly men. In recent years, pharmacotherapy of BPH has increased the efficacy, including combination treatment mostly with two drug classes, namely, 5-α-reductase inhibitors and α-1-adrenolytics (alpha blockers) with a different pharmacological activity. Although pharmacological treatment of BPH is a success story in urology, daily practice suggests that several medical needs remain unmet...
August 2018: Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society
https://www.readbyqxmd.com/read/30549500/how-to-read-a-research-paper-an-exercise-in-critical-thinking-in-the-context-of-an-epidemiologic-study-on-tamsulosin-and-the-risk-of-dementia
#4
Chittaranjan Andrade
A recent study of the relationship between tamsulosin and dementia found that, in propensity score-matched analyses that adjusted for measured risk factors for dementia, the use of tamsulosin to treat benign prostatic hyperplasia (BPH) was associated with a small but significant increase in the risk of incident dementia relative to untreated BPH, BPH treated with the 5α-reductase inhibitors dutasteride and finasteride, and BPH treated with the α adrenoceptor blockers doxazosin, terazosin, and alfuzosin. The choice of control groups addressed confounding by indication, confounding by disease severity, and confounding by pharmacologic drug class...
December 11, 2018: Journal of Clinical Psychiatry
https://www.readbyqxmd.com/read/30549493/why-odds-ratios-can-be-tricky-statistics-the-case-of-finasteride-dutasteride-and-sexual-dysfunction
#5
Chittaranjan Andrade
Finasteride and dutasteride are 5α-reductase inhibitor drugs that are used to treat benign prostatic hyperplasia (BPH). Randomized controlled trials (RCTs) conducted in men with BPH show that these drugs impair libido and cause erectile dysfunction. Meta-analyses of the RCTs confirm the findings, estimating odds ratio (OR) values for these adverse effects at around 1.50. A problem with meta-analyses that do not report absolute risks with drug vs placebo and that extract ORs instead of relative risks (RRs) from RCT data is that it is hard for the reader to know how to interpret the findings and communicate them to patients...
November 27, 2018: Journal of Clinical Psychiatry
https://www.readbyqxmd.com/read/30548821/is-obstructive-sleep-apnea-syndrome-related-to-nocturia
#6
Burak Arslan, Cem T Gezmis, Buğra Çetin, Serkan Gönültas, Ersin Gökmen, Okan Gürkan, Enver Ozdemir
OBJECTIVE: The aim of this study was to investigate the relationship between obstructive sleep apnea syndrome (OSAS) and lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). METHODS: This multicenter study was performed on 122 male patients with dyspnea and/or sleep disorder. Patient characteristics were recorded. All patients underwent full-night polysomnography, and the apnea-hypopnea index (AHI) was calculated. LUTS were evaluated using the International Prostate Symptom Score (IPSS) and prostate volume was calculated by transabdominal ultrasonography...
December 12, 2018: Lower Urinary Tract Symptoms
https://www.readbyqxmd.com/read/30548639/tadalafil-15-years-journey-in-male-erectile-dysfunction-and-beyond
#7
Nermin S Ahmed
Hit, Lead & Candidate Discovery Tadalafil, Cialis, Eli Lilly & Co./ICOS, (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6] pyrido[3,4-b]indole-1,4-dione, was first discovered in 2003. It was reported to have high diastereospecificity for phosphodiesterase 5 (PDE5) inhibitions. The cis-(6R, 12aR) enantiomer is the most active enantiomer. Tadalafil showed PDE5 inhibition with IC50  = 5 nM. It possesses high selectivity for PDE5 versus PDE1-4 and PDE6. Tadalafil is more selective to PDE5 against PDE6 whereas sildenafil, another commercially available PDE5 inhibitor shows similar potencies to inhibit PDE5 and PDE6...
December 13, 2018: Drug Development Research
https://www.readbyqxmd.com/read/30545338/the-evaluation-of-nocturia-in-patients-with-lower-urinary-tract-symptoms-suggestive-of-benign-prostatic-hyperplasia-and-the-analysis-of-the-curative-effect-after-medical-or-placebo-therapy-for-nocturia-a-randomized-placebo-controlled-study
#8
Zhigang Xue, Yunhua Lin, Yongguang Jiang, Nengbao Wei, Jinwen Bi
BACKGROUND: To study nocturia in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) after medical or placebo treatment. METHODS: Patients with LUTS suggestive of BPH from several community clinics were included. Patients completed the International Prostate Symptom Score (I-PSS) questionnaire and a 3-day voiding diary. Urinalysis, prostate-specific antigen (PSA) measurement, and prostate ultrasonography were performed...
December 13, 2018: BMC Urology
https://www.readbyqxmd.com/read/30545222/infiltration-of-prostate-cancer-by-cd204-and-cd3-cells-correlates-with-erg-expression-and-tmprss2-erg-gene-fusion
#9
A Burdova, P Rulisek, J Bouchal, M Král, V Student, Z Kolar
BACKGROUND: The aim of the study was to detect CD204 + and CD3 + cells in the infiltrate of benign prostatic hyperplasia, prostatic intraepithelial neoplasia and prostatic cancer in prostate specimens after radical prostatectomy. Another goal was to determine correlation of the intensity of the infiltration with ERG oncoprotein expression as well as with the presence of activat-ing translocation TMPRSS2-ERG. MATERIALS AND METHODS: To confirm the translocation, we used fluorescence in situ hybridization...
2018: Klinická Onkologie: Casopis Ceské a Slovenské Onkologické Spolecnosti
https://www.readbyqxmd.com/read/30544543/botanical-formulation-hx109-ameliorates-tp-induced-benign-prostate-hyperplasia-in-rat-model-and-inhibits-androgen-receptor-signaling-by-upregulating-ca-2-camkk%C3%AE-and-atf3-in-lncap-cells
#10
Seonung Lim, Wonwoo Lee, Doo Suk Lee, In-Jeong Nam, Nayoung Yun, Yoonseon Jeong, Taewoong Rho, Sunyoung Kim
Benign prostatic hyperplasia (BPH) is a common disease in the elderly male population throughout the world. Among other factors, androgen dysregulation has been known to play major roles in its pathogenesis. HX109 is a botanical formulation prepared from a mixture of Taraxacum officinale , Cuscuta australis , and Nelumbo nucifera , which have traditionally been used-usually along with other plants-to treat urinary diseases. An ethanol extract was prepared from a mixture of these three plants, and its quality was controlled through cell-based bioassays and by quantification of several marker compounds by high-performance liquid chromatography (HPLC)...
December 7, 2018: Nutrients
https://www.readbyqxmd.com/read/30534441/simultaneous-antegrade-and-retrograde-endoscopic-surgery-for-benign-prostatic-hyperplasia-with-vesical-calculi-a-single-centre-experience
#11
Tarun Javali, Arvind Nayak K, S M L Prakash Babu
Objective: To describe the effectiveness and safety of our novel technique of simultaneous percutaneous cystolithotripsy with transurethral resection of prostate (TURP) for patients with benign prostatic hyperplasia (BPH) complicated with large vesical calculi. Patients and methods: This was a retrospective analysis of 25 patients who underwent simultaneous percutaneous cystolithotripsy with TURP between January 2012 and January 2016. Technique: A 28-F Amplatz sheath was inserted percutaneously into the bladder after sequential dilatation under cystoscopic guidance...
December 2018: Arab Journal of Urology
https://www.readbyqxmd.com/read/30534440/thulium-laser-enucleation-of-the-prostate-thulep-results-complications-and-risk-factors-in-139-consecutive-cases
#12
Marco Raber, Noor N P Buchholz, Augusto Vercesi, Nashaat A Hendawi, Vincenzo Inneo, Giuseppe Di Paola, Lorenzo Tessa, Ismail M Hassan
Objectives: To report our experience with the emerging technique of thulium laser enucleation of the prostate (ThuLEP) for the treatment for prostate hyperplasia. Patients and methods: Our inclusion criteria were an International Prostate Symptom Score (IPSS) of >15 and a quality-of-life (QoL) score of >3 in patients with confirmed bladder outflow obstruction, no longer responsive to medical therapy, with a significant post-void residual urine volume (PVR; >100 mL), with or without recurrent urinary tract infection and/or acute urinary retention...
December 2018: Arab Journal of Urology
https://www.readbyqxmd.com/read/30534439/oral-desmopressin-in-nocturia-with-benign-prostatic-hyperplasia-a-systematic-review-of-the-literature
#13
REVIEW
Diaa-Eldin Taha, Omar M Aboumarzouk, Ahmed A Shokeir
Objective: To evaluate the effect of oral desmopressin in patients with nocturia associated with benign prostatic hyperplasia (BPH). Patients and methods: With a rise of the use of oral desmopressin in the treatment of nocturia in patients with BPH, a systematic review was performed according to the Cochrane systematic reviews guidelines and in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. Results: The literature search yielded 18 studies...
December 2018: Arab Journal of Urology
https://www.readbyqxmd.com/read/30531531/histopathologic-false-positive-diagnoses-of-prostate-cancer-in-the-age-of-immunohistochemistry
#14
Luis Beltran, Amar S Ahmad, Holly Sandu, Sakunthala Kudahetti, Geraldine Soosay, Henrik Møller, Jack Cuzick, Daniel M Berney
There are few studies into the rate and causes of histopathologic false-positive diagnosis of prostate cancer. Only 2 of these, including a previous one from our group, incorporate survival data. In addition, in none of the previous studies had immunohistochemistry (IHC) been originally requested on any of the misdiagnosed cases. Diagnostic biopsies (n=1080) and transurethral resection of prostate specimens (n=314) from 1394 men with clinically localized prostate cancer diagnosed in the United Kingdom but treated conservatively between 1990 and 2003 were reviewed by a panel of 3 genitourinary pathologists...
December 7, 2018: American Journal of Surgical Pathology
https://www.readbyqxmd.com/read/30529932/an-immunohistochemical-study-of-t-and-b-lymphocyte-density-in-prostatic-hyperplasia-and-prostate-carcinoma-in-dogs
#15
Chiara Palmieri, Grace Hood, Carlos Eduardo Fonseca-Alves, Renée Laufer-Amorim, Rachel Allavena
The aim of this study was to characterise T and B lymphocyte density in 6 normal prostates, 15 benign prostatic hyperplasia (BPH) and 24 prostate carcinomas (PCs) in dogs by immunohistochemistry. Results revealed a statistically significant increase of T and B cells in PC compared to normal specimens and BPH. Regarding PC histological variants, lower number of CD3+ and CD79+ lymphocytes were observed in the most undifferentiated (solid) type. CD3+ cell density was positively correlated with survival time. These results may help in understanding the immunological mechanisms regulating BPH and PC development and progression, as well as providing background data for future immunotherapeutic trials...
November 27, 2018: Research in Veterinary Science
https://www.readbyqxmd.com/read/30529422/evaluation-of-the-therapeutic-effect-against-benign-prostatic-hyperplasia-and-the-active-constituents-from-epilobium-angustifolium-l
#16
Liqing Deng, Wei Zong, Xueying Tao, Shuang Liu, Zhiying Feng, Yuping Lin, Zhihua Liao, Min Chen
ETHNOPHARMACOLOGICAL RELEVANCE: Plants of Epilobium angustifolium are popular in China to treatment of traumatic injury, subduing inflammation and menstrual disorders. In European, the preparations or extracts containing E. angustifolium are popular to treat prostate diseases. Recent research suggested that E. angustifolium showed therapeutic effects in early stage of BPH, inflammation of urethra and prostate, as well as micturition problems. And the related researches were focus on aqueous extract and its main constituent of oenothein B...
December 5, 2018: Journal of Ethnopharmacology
https://www.readbyqxmd.com/read/30528716/predictors-of-post-operative-urinary-incontinence-after-holmium-laser-enucleation-of-the-prostate-12-months-follow-up
#17
Laura B Cornwell, Garrett E Smith, Jessica E Paonessa
OBJECTIVES: To identify pre- and peri-operative factors associated with incontinence after holmium laser enucleation of the prostate for benign prostatic hyperplasia. METHODS: Retrospective review of our single-surgeon database identified 88 patients with 12 months follow up who underwent surgery between December 2014 and November 2016. Post-operative urinary incontinence was defined as one or more pads per day. Patients were evaluated at 6 weeks, 6 months and 12 months post-operatively...
December 4, 2018: Urology
https://www.readbyqxmd.com/read/30526803/drillcut-tm-vs-versacut-tm-prostate-tissue-morcellation-devices-after-holmium-laser-enucleation-a-prospective-randomized-controlled-trial
#18
Ahmed Ibrahim, Mostafa M Elhilali, Mohammed A Elkoushy, Sero Andonian, Serge Carrier
INTRODUCTION: We aimed to compare efficacy, safety, and cost of disposables of the DrillCutTM morcellator with the VersaCutTM morcellator after holmium laser enucleation of the prostate (HoLEP). METHODS: After obtaining ethical approval, consecutive patients undergoing HoLEP for symptomatic benign prostatic hyperplasia were randomized to have their enucleated prostates morcellated by either Karl Storz® DrillCutTM or Lumenis® VersaCutTM morcellators. All procedures were performed by two experienced urologists...
December 3, 2018: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/30523608/silodosin-an-update-on-efficacy-safety-and-clinical-indications-in-urology
#19
REVIEW
Luca Villa, Paolo Capogrosso, Umberto Capitanio, Alberto Martini, Alberto Briganti, Andrea Salonia, Francesco Montorsi
INTRODUCTION: Silodosin determines smooth muscle relaxation in bladder and prostate tissues, increases bladder blood flow in conditions of chronic bladder ischemia and regulates the activity of transcriptional factors responsible for stromal growth and prostate hyperplasia. Phase III trials have already demonstrated the efficacy and safety of silodosin in the treatment of patients bothered by lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). OBJECTIVE: We aimed to describe the rationality for the use of silodosin and to summarize the current literature on the use of Silodosin for the treatment of LUTS...
December 6, 2018: Advances in Therapy
https://www.readbyqxmd.com/read/30522625/two-unusual-reports-of-urogenital-tuberculosis-one-putty-kidney-and-another-in-association-with-benign-prostatic-hyperplasia
#20
Krishnendu Mondal, Rupali Mandal
In India urogenital tuberculosis is the second commonest form of extra-pulmonary tuberculosis. Kidney is the highest and prostate is the least affected urogenital organ. But the extreme stage of renal tuberculosis named as 'putty' kidney is a rare manifestation. In general most cases of urogenital tuberculosis are quasi-symptomatic, and therefore an uttermost apprehension is needed from physicians to intercept such cases at the earliest. In this presentation we describe a case of 'putty' kidney, and another incidental association of prostate tuberculosis with benign prostatic hyperplasia...
October 2018: Indian Journal of Tuberculosis
keyword
keyword
168483
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"